Endovascular treatment of intracranial infectious aneurysms

Simple item page
dc.contributor.authorEsenkaya A.
dc.contributor.authorDuzgun F.
dc.contributor.authorCinar C.
dc.contributor.authorBozkaya H.
dc.contributor.authorEraslan C.
dc.contributor.authorOzgiray E.
dc.contributor.authorOran I.
dc.date.accessioned2024-07-22T08:12:06Z
dc.date.available2024-07-22T08:12:06Z
dc.date.issued2016
dc.description.abstractIntroduction: Intracranial infectious aneurysm (IIA) accounts for less than 5 % of all intracranial aneurysms. The aim of this study was to evaluate the role of endovascular treatment for IIA. Methods: During a 14-year period, 15 patients (age range, 2–68 years; mean, 42.8 years) with 17 aneurysms were diagnosed with IIA and treated via an endovascular route at our institution. The IIA diagnosis was based on clinical and laboratory findings of infection, echocardiography results, and digital subtraction angiography that were collected retrospectively. All patients were clinically and radiologically followed. The modified Rankin scale was used to evaluate clinical outcome. Results: Among 15 patients, 12 presented with ruptured aneurysms (7 intraparenchymal hematoma, 4 subarachnoid hemorrhage, 1 subdural hematoma), 2 with cerebral infarcts, and 1 with pansinusitis and epidural abscess. All but one aneurysm were distally located in intracranial circulation, 14 were in anterior, and the remaining 3 were in posterior circulation. The final diagnosis was based on aneurysm morphology, location, and clinical laboratory findings. Endovascular treatment was scheduled initially for all IIAs; 13 of 17 IIAs underwent endovascular parent vessel occlusion, 3 underwent spontaneous parent vessel occlusion while waiting for intervention, and the remaining patient was treated by intrasaccular coil occlusion. There were no instances of perioperative neurological complications. Late clinical and radiological outcomes included absence of endovascular treatment related to mortality and aneurysm recurrence. Conclusion: Endovascular treatment may be performed safely at the time of diagnosis for at least symptomatic IIAs under the protective effect of antibiotic treatment. © 2015, Springer-Verlag Berlin Heidelberg.
dc.identifier.DOI-ID10.1007/s00234-015-1633-2
dc.identifier.issn00283940
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/15910
dc.language.isoEnglish
dc.publisherSpringer Verlag
dc.subjectAdult
dc.subjectAged
dc.subjectAneurysm, Infected
dc.subjectAnti-Bacterial Agents
dc.subjectCerebral Angiography
dc.subjectChild
dc.subjectChild, Preschool
dc.subjectCombined Modality Therapy
dc.subjectEmbolization, Therapeutic
dc.subjectEndovascular Procedures
dc.subjectHemostatics
dc.subjectHumans
dc.subjectIntracranial Aneurysm
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectTreatment Outcome
dc.subjectantibiotic agent
dc.subjectC reactive protein
dc.subjectantiinfective agent
dc.subjecthemostatic agent
dc.subjectadult
dc.subjectaged
dc.subjectaneurysm rupture
dc.subjectantibiotic therapy
dc.subjectArticle
dc.subjectartificial embolism
dc.subjectbrain hemorrhage
dc.subjectbrain infarction
dc.subjectbrain infection
dc.subjectchild
dc.subjectclinical article
dc.subjectclinical laboratory
dc.subjectcomputed tomographic angiography
dc.subjectcomputed tomography scanner
dc.subjectcontrolled study
dc.subjectcraniotomy
dc.subjectdigital subtraction angiography
dc.subjectechocardiography
dc.subjectechography
dc.subjectendovascular aneurysm repair
dc.subjectepidural abscess
dc.subjecterythrocyte sedimentation rate
dc.subjectfemale
dc.subjectfollow up
dc.subjecthuman
dc.subjectintracranial aneurysm
dc.subjectintracranial infectious aneurysm
dc.subjectintraparenchymal hematoma
dc.subjectmale
dc.subjectmiddle aged
dc.subjectnuclear magnetic resonance imaging
dc.subjectnuclear magnetic resonance scanner
dc.subjectpreschool child
dc.subjectpriority journal
dc.subjectRankin scale
dc.subjectretrospective study
dc.subjectrisk factor
dc.subjectschool child
dc.subjectsinusitis
dc.subjectsubarachnoid hemorrhage
dc.subjectsubdural hematoma
dc.subjecttreatment duration
dc.subjectAneurysm, Infected
dc.subjectartificial embolization
dc.subjectbrain angiography
dc.subjectcase report
dc.subjectcomplication
dc.subjectdiagnostic imaging
dc.subjectendovascular surgery
dc.subjectintracranial aneurysm
dc.subjectmultimodality cancer therapy
dc.subjectprocedures
dc.subjecttreatment outcome
dc.titleEndovascular treatment of intracranial infectious aneurysms
dc.typeArticle

Files

Collections

Scopus Koleksiyonu